Tandem Diabetes Care Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Why don't we kick this off? So it's Patrick on the U.S. Medtech team.
I got the exciting disclaimers for you guys. So for the disclosures, please go to Morgan Stanley research disclosures website at morganstanley.com/researchdisclosures. I'm sure all will be going there. If you have any questions, feel free to reach out to your sales rep. So I'll say there bye-bye.
So massive thank you to Tandem. We've got John Sheridan, obviously, and Leigh Vosseller here, agreed to join us as CEO and CFO. An open fireside chat should be a lot of fun. So thank you for joining us.
Nice to be here, Patrick.
Questions & Answers
Thank you. Maybe as an opener, just to sort of set the scene, what do you feel gives Tandem its competitive edge in the pump market overall? And how do you feel like what's the DNA of the company that really gives the edge to Tandem?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
